| Name | Pateclizumab |
|---|
| Description | Pateclizumab (MLTA3698A) is a humanized antibody against lymphotoxin α (LTα), a transiently expressed cytokine on activated B and T cells (Th1, Th17), which are implicated in rheumatoid arthritis (RA) pathogenesis[1]. |
|---|---|
| Related Catalog | |
| Target |
lymphotoxin α |
| References |
| No Any Chemical & Physical Properties |